ИСТИНА

Krzyzanowski M.

Соавторы: Романов И.С., Gianoukakis A.G., Hughes B., Kenda B., Kulikoff X., Linder T., Panaseykin Y., Дедус Ф.Ф., Роже М.и., Bauer N., Binder K, Bogodistov I.S., Cohen A.J. показать полностью..., Donkelaar A., Garbinsky D., Gianoukakis A., J P., João P.C., Konda B., Leboulleux S., Leboullex S., Levy R.C., M T.M., Ma R., Martin R., PAUL C., Panaseykin V., Park Y., Taylor A., Wang S., YJ, da Silva A.M., de la Fouchardiere C., de la Fouchardiere C., de la Fourchardiere C., Семутникова Е.Г., Чубарова Н.Е., Шариф А.Х.

4 статьи

Количество цитирований статей в журналах по данным Web of Science: 122, Scopus: 136

IstinaResearcherID (IRID): 1980722

Деятельность

• Статьи в журналах

  • • 2021 A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
    • Brose Marcia S., Panaseykin Yury, Konda Bhavana, de la Fouchardiere Christelle, Hughes Brett G.M., Gianoukakis Andrew G., Park Young Joo, Romanov Ilia, Krzyzanowska Monika K., Leboulleux Sophie, Binder Terri A., Dutcus Corina, Xie Ran, Taylor Matthew H.
    • в журнале Journal of Clinical Endocrinology and Metabolism, издательство The Endocrine Society (United States), том 107, № 3, с. 776-787 DOI
  • • 2021 Health-related quality-of-life (HRQoL) analyses from study 211: A phase 2 study in patients (pts) with radioiodine-refractory differentiated thyroid cancer (RR-DTC) treated with 2 starting doses of lenvatinib (LEN)
    • MH Taylor, Leboullex S., Panaseykin V., Konda B., de la Fourchardiere C., Hughes BGM, Gianoukakis AG, Park YJ, Romanov I., Krzyzanowska MK, Garbinsky D., Sherif B., Pan JJ, Binder T., Sauter N., Xie R., Brose MS
    • в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 32, с. 1205-1210 DOI
  • • 2020 A multicenter, randomized, double-blind, phase II study of lenvatinib (LEN) in patients (pts) with radioiodine-refractory differentiated thyroid cancer (RR-DTC) to evaluate the safety and efficacy of a daily oral starting dose of 18 mg vs 24 mg
    • Brose M.S., Panaseykin Y., Konda B., de la Fouchardiere C., Hughes B.G.M, Gianoukakis A.G., Park Y.J., Romanov I., Krzyzanowska M.K., Binder T., Dutcus C., Xie R., Taylor M.H.
    • в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 31, с. S1409-S1409 DOI
  • 
    • 2011 Satellite-based estimates of ground-level fine particulate matter during extreme events: A case study of the Moscow fires
    • Donkelaar A., Martin R., Levy R.C., da Silva A.M., Krzyzanowski M., Chubarova N.E., Semutnikova E., Cohen A.J.
    • в журнале Atmospheric Environment, издательство Elsevier BV (Netherlands), том 45, № 34, с. 6225-6232